Swiss Life Group

ZWEI Wealth Experts is a wealth management firm based in Zurich, Switzerland, established in 2014. The company aims to create a transparent and controlled investment environment for its clients by serving as an independent advisor. ZWEI Wealth emphasizes a personalized approach to asset management, with its executive management team overseeing the firm's operations and investment strategies. Through its innovative wealth management ecosystem, the firm seeks to empower investors by providing them with clarity and oversight in their financial decisions.

DataBank Holdings, Ltd. is a data center and co-location company headquartered in Dallas, Texas, with additional facilities in the Dallas/Fort Worth area, Minneapolis/St. Paul, Eagan, Kansas City, and Atlanta. Founded in 2004, DataBank provides a comprehensive array of services, including co-location solutions that ensure security, power configurations, and cooling. The company also offers managed services such as cloud computing, virtual hosting, network connectivity, and security, along with consulting services that encompass design and implementation, migration, and continuity planning. DataBank emphasizes compliance with various industry standards, including those for payment card security and health data protection. Catering to a diverse clientele across sectors like healthcare, finance, gaming, and hospitality, DataBank is committed to optimizing IT environments and ensuring data availability for enterprises.

Upmin is a real estate technology company that operates an online platform for property management. It automates various processes such as accounting, utility bill payments, tenant management, and property maintenance, saving landlords and owners time and money. Additionally, Upmin offers optional rental services including tenant search assistance from advertising to handover.

PriceHubble is a Swiss B2B proptech company that specializes in creating innovative digital solutions for the real estate industry, focusing on property valuations and market insights. Utilizing advanced analytics and machine learning algorithms, PriceHubble's platform offers accurate data-driven insights, including valuations, market analyses, and value forecasts, which enhance decision-making for various stakeholders in the real estate value chain, such as banks, asset managers, developers, property managers, and real estate agents. The company aims to increase transparency in the market and improve engagement with end consumers. Active in nine countries, including Switzerland, France, Germany, and Japan, PriceHubble employs over 130 people worldwide, underscoring its commitment to delivering robust real estate analytics and fostering informed investment decisions.

Zenhomes provides a one-stop shop for private landlords and property managers. The company's digital platform simplifies property and tenant management.

Vermietet.de is a Berlin-based company that aims to simplify and enhance real estate ownership through its innovative property management platform. Recognizing the complexities involved in property management, the company provides tools that assist property owners in handling various administrative tasks, including document creation, property maintenance, tenant search, and communication. By streamlining these processes, Vermietet.de enables landlords to efficiently manage property valuation, utility cost calculations, and monthly rental payment checks, making property management more transparent and user-friendly.

Fincentrum is one of the leading financial advisory consulting firms in the Czech Republic, renowned for its commitment to high-quality advisory services that prioritize client interests. The company assists individuals and businesses in navigating the complexities of finance by providing access to a wide range of financial institutions and their products. These offerings include insurance, loans, investments, savings, and pension solutions, which cater to diverse financial needs. By leveraging partnerships with various financial entities, Fincentrum ensures that its clients receive tailored advice and solutions to effectively address their unique financial situations.

LaFinBox is a free and secure mobile application designed to manage money across various financial institutions. Established in 2015 by Swiss Life, a prominent player in the insurance and wealth management sector since 1857, LaFinBox centralizes all financial and investment support, including current accounts, bank cards, loans, passbooks, employee savings, life insurance, PEA, mortgage, and more. The app aims to provide users with a comprehensive overview of their finances, making it easier to manage and track their financial activities.

PriceHubble is a Swiss B2B proptech company that specializes in creating innovative digital solutions for the real estate industry, focusing on property valuations and market insights. Utilizing advanced analytics and machine learning algorithms, PriceHubble's platform offers accurate data-driven insights, including valuations, market analyses, and value forecasts, which enhance decision-making for various stakeholders in the real estate value chain, such as banks, asset managers, developers, property managers, and real estate agents. The company aims to increase transparency in the market and improve engagement with end consumers. Active in nine countries, including Switzerland, France, Germany, and Japan, PriceHubble employs over 130 people worldwide, underscoring its commitment to delivering robust real estate analytics and fostering informed investment decisions.

Bexio AG is a Swiss company that specializes in providing cloud-based business and accounting software tailored for small and medium-sized enterprises. Founded in 2013 and based in Rapperswil, the company was previously known as easySYS AG before rebranding in 2015. Bexio AG focuses on simplifying accounting processes and enhancing business management through its user-friendly platform, which employs a standardized interface to facilitate interactions between businesses and their trustees, banks, and service providers. As of mid-2018, Bexio operates as a subsidiary of Schweizerische Mobiliar Versicherungsgesellschaft AG, reflecting its commitment to supporting the growth and efficiency of small businesses in Switzerland.

Phenex Pharmaceuticals AG is a privately held drug discovery and development company based in Ludwigshafen, Germany, with additional facilities in Heidelberg. Founded in 2002, the company specializes in small-molecule drug discovery, focusing on liver diseases, intestinal diseases, and cancer. Its research includes developing retinoid-acid receptor-related orphan receptor gamma t (RORγt) inverse agonists for autoimmune diseases and farnesoid X receptor (FXR) agonists for non-alcoholic steatohepatitis. Phenex aims to identify novel molecular mechanisms and develop innovative therapeutics, having already translated two such mechanisms into proprietary small molecules.

AWD Holding AG, along with its subsidiaries, provides individual financial advice and planning services in Europe. It focuses on provision of hedge fund and old-age pension products, and long-term growth of assets. The company provides retirement provision services; and private asset accumulation and asset retirement planning services for private customers. It serves customers in Germany, Austria, Czech Republic, Hungary, Poland, Slovakia, Great Britain, and Switzerland. AWD Holding AG was formerly known as Allgemeiner Wirtschaftsdienst. The company was founded in 1988 and is based in Hanover, Germany. It has independent representative offices in Germany, the United Kingdom, Austria, Switzerland, and Central and Eastern Europe. AWD Holding AG operates as a subsidiary of Swiss Life Deutschland Holding GmbH.

Enanta Pharmaceuticals, Inc., established in 1998 and headquartered in Watertown, Massachusetts, is a biotechnology company dedicated to discovering and developing small molecule drugs for treating viral infections and liver diseases. Its primary focus areas include hepatitis C virus (HCV), hepatitis B virus (HBV), non-alcoholic steatohepatitis (NASH), respiratory syncytial virus (RSV), and human metapneumovirus (hMPV). Enanta offers glecaprevir, marketed as MAVYRET and MAVIRET, for chronic HCV treatment. Through a collaborative agreement with Abbott Laboratories, the company has developed paritaprevir, an HCV NS3/4A protease inhibitor. Enanta's pipeline also includes direct-acting antiviral inhibitors against HCV and other viral targets.

Iolon, Inc. is a privately held company specializing in optical networking components, focusing on high-performance tunable devices for advanced fiber optic networks. The company's initial product is a high-powered external cavity tunable laser source, designed for high bit rate and long-haul applications. Iolon also plans to expand its product offerings to include tunable filters, optical switches, polarization controllers, spectral monitors, and universal transponders. The company leverages its platform technology, which incorporates patented micro-optics, MEMS, and advanced servo control technologies, to facilitate advanced automation for high-volume manufacturing. Iolon's products are critical for transmitting, monitoring, and receiving optical signals within optical networks and for test and measurement equipment.

Zeptosens is an ultra-sensitive microarray platform for quantitative proteomic investigations. It provides microarray platforms for sensitive and quantitative protein profiling, and signaling pathway analysis by reverse protein arrays. Its products include ZeptoREADER, a microarray reader for Zeptosens planar wave guide technology; ZeptoMARK protein microarray chips and ZeptoCARRIER for various data points, which are split into arrays. The company also offers proteinarray services, including protein profiling for various samples, such as cell lines, tissues, microdissected cells, and depleted serums; and assay development. In addition, it provides training services, technical and applications support, and technical service and maintenance. The company’s products are used in various applications, including biomarker/target discovery and validation, cell-based screening, mode of action profiling, selectivity profiling, and toxicology investigation. Its customers include pharma research and development companies, biotech companies, and academic institutions. Zeptosens was founded in 2002 and is headquartered in Wilderswil, Switzerland.

Acorda Therapeutics is a biopharmaceutical company focused on developing and commercializing therapies for neurological disorders. Founded in 1995 and headquartered in Ardsley, New York, the company markets Ampyra (dalfampridine), an oral drug approved by the FDA to improve walking in patients with multiple sclerosis (MS). In Europe, this drug is marketed as Fampyra. Acorda also markets Selincro for alcohol dependence in Europe and Zanaflex Capsules for spasticity management. Additionally, the company develops Inbrija for treating OFF periods in Parkinson’s disease and ARCUS for acute migraine. Other pipeline products include rHIgM22 for MS and Cimaglermin alfa for heart failure. Acorda has collaborations with Biogen Inc. for Ampyra's development and commercialization.